To evaluate the 1-year efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF) in patients with acute central serous chorioretinopathy (CSC).
Efficacy of Intravitreal Anti-vascular Endothelial Growth Factor in Acute Central Serous Chorioretinopathy: One-Year Results
Posted by Seung Jun Lee on Oct 10, 2013 in Anti VEGF, Central serous chorioretinopathy |
Comments Off on Efficacy of Intravitreal Anti-vascular Endothelial Growth Factor in Acute Central Serous Chorioretinopathy: One-Year Results
